Skip to main content
SpringerLink
Log in

Alterations and polymorphisms of the estrogen receptor gene in breast cancer

Breast Cancer volume 4, pages 57–66 (1997)Cite this article

Abstract

The existence of hormone-independent tumors is a substantial problem for the present endocrine treatment of breast cancers. Recently, numerous variant estrogen receptors (ERs) at the mRNA level have been detected with base pair insertions, transitions, and deletions, as well as alternative splicing, yielding deletion of exon 3, 5, or 7. It has been shown that the loss of hormone dependence in breast tumors is partly due to the presence of mutated or truncated ERs that can activate the transcription of an estrogen-regulatable gene in the absence of estrogen. The mechanism of the loss of hormone dependency is, however, still very complex. Thus, further work assessing the correlation between clinical behavior and ER variants is required to determine whether these variants play a role in hormone~resistant disease. Additionally, a possible linkage to the ER gene has been found in some breast cancer families, suggesting that either the ER gene itself or an adjacent gene may be breast cancer susceptibility genes.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Abbreviations

ER:

Estrogen receptor

PgR:

Progesterone receptor

kb:

Kilobase

kDa:

Kilodalton

SSCP:

Single strand conformation polymorphism

PCR:

Polymerase chain reaction

RT:

Reverse transcription

References

  1. Jensen EV, Jacobson HI: Basic guides to the mechanism of estrogen action.Recent Prog Horm Res 18:387–414, 1962.

    CAS  Google Scholar 

  2. Nagai R, Kataoka M, Kobayashi S,et al: Estrogen and progesterone receptors in human breast cancer with concomitant assay of plasma 17β-estradiol, progesterone, and prolactin levels.Cancer Res 39: 1835–1840, 1979.

    Google Scholar 

  3. Evans RM: The steroid and thyroid hormone receptor superfamily.Science 240:889–895, 1988.

    Article  PubMed  CAS  Google Scholar 

  4. Farrell SE, Lees JA, White R,et al: Characterization and localization of steroid binding and dimerization activities in the mouse estrogen receptor.Cell 60:953- 962, 1990.

    Article  Google Scholar 

  5. Guichon-Mantel A, Loosfelt H, Lescap P,et al: Mechanisms of nuclear localization of the progesterone receptor; Evidence for interaction of monomers.Cell 57:1147–1154, 1989.

    Article  Google Scholar 

  6. Howard KJ, Holley SJ, Yamamoto KR,et al: Mapping of the HSP90 binding region of the glucocorticoid receptor.J Biol Chem 265:11928–11935, 1990.

    PubMed  CAS  Google Scholar 

  7. Green S, Walter P, Kumar V,et al: Human oestrogen receptor cDNA; Sequence, expression and homology to v-erb-A.Nature 320:134–139, 1986.

    Article  PubMed  CAS  Google Scholar 

  8. Menasce LP, White GRM, Harrison CJ,et al: Localization of the estrogen receptor locus(ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique.Genomics 17:263–265, 1993.

    Article  PubMed  CAS  Google Scholar 

  9. Ponglikitmongkol M, Green S, Chambon P: Genomic organization of the human oestrogen receptor gene.EMBO J 7:3385–3388, 1988.

    PubMed  CAS  Google Scholar 

  10. Green GL, Gilna P, Waterfield M,et al: Sequence and expression of human estrogen receptor complementary DNA.Science 231:1150–1154, 1986.

    Article  Google Scholar 

  11. Liu E, Dollbrum C, Scott G: Molecular lesions involved in the progression of a human breast cancer.Oncogene 3:323–327, 1988.

    PubMed  CAS  Google Scholar 

  12. Sluyser M: Role of estrogen receptor variants in the development of hormone resistance in breast cancer.Clin Biochem 25:407–414, 1992.

    Article  PubMed  CAS  Google Scholar 

  13. Zuppan P, Hall JM, Lee MK,et al: Possible linkage of the estrogen receptor gene to breast cancer in a family with late-onset disease.Am J Hum Genet 48:1065–1068, 1991.

    PubMed  CAS  Google Scholar 

  14. Andersen TI, Heimdal KR, Skrede M,et al: Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility.Hum Genet 94:665–670, 1994.

    PubMed  CAS  Google Scholar 

  15. Kou EH, Ro J, Wildrick DM,et al: Analysis of the estrogen receptor gene structure in human breast cancer.Anticancer Res 9:1841–1846, 1989.

    Google Scholar 

  16. Matsuo K: The analysis of the estrogen receptor gene expression in human breast cancer tissues.J Nagoya Med Assoc 42:1001–1011, 1991 (in Japanese).

    CAS  Google Scholar 

  17. Watts CK, Handel ML, King RJ,et al: Oestrogen receptor gene structure and function in breast cancer.J Steroid Biochem Mol Biol 41:529–536, 1992.

    Article  PubMed  CAS  Google Scholar 

  18. Nembrot M, Quintana B, Morden J: Estrogen receptor gene amplification is found in some estrogen receptor-positive human breast tumors.Biochem Biophys Res Commun 166:601–607, 1990.

    Article  PubMed  CAS  Google Scholar 

  19. Roodi N, Bailey LR, Kao WY,et al: Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer.JNCI 87:446- 451, 1995.

    Article  PubMed  CAS  Google Scholar 

  20. Iwase H, Greenman JM, Barnes DM,et al: Sequence variants of the estrogen receptor (ER) gene found in breast cancer patients with ER negative and progesterone receptor positive tumors.Cancer Lett 108:179- 184, 1996.

    Article  PubMed  CAS  Google Scholar 

  21. Iwase H, Greenman JM, Barnes DM,et al: Loss of heterozygosity of the oestrogen receptor gene in breast cancer.Br J Cancer 71:448–450, 1995.

    PubMed  CAS  Google Scholar 

  22. McGuire WL, Chamness GC, Fuqua SA: Abnormal oestrogen receptor in clinical breast cancer.Eur J Cancer 28:309–10, 1992.

    Article  PubMed  CAS  Google Scholar 

  23. Wei LL: Transcriptional activation of the estrogen receptor.Clin Chem 39:341–345, 1993.

    PubMed  CAS  Google Scholar 

  24. Wiltschke C, Fuqua SAW: Clinical relevance of estrogen receptor variants in breast cancer.Trends Endocrinol Metab 6:77–82, 1995.

    Article  PubMed  CAS  Google Scholar 

  25. Barret-Lee PJ, Travers MT, McClelland RA,et al: Characterization of estrogen receptor messenger RNA in human breast cancer.Cancer Res 47:6653- 6659, 1987.

    Google Scholar 

  26. Piva R, Bianchini E, Kumar VL,et al: Estrogen induced increase of estrogen receptor RNA in human breast cancer cells.Biochem Biophys Res Commun 155:943–948, 1988.

    Article  PubMed  CAS  Google Scholar 

  27. Henry JA, Nicholson S, Hennessy C,et al: Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer; Relation to oestrogen receptor mRNA levels and response to tamoxifen therapy.Br J Cancer 61:32–38, 1990.

    PubMed  CAS  Google Scholar 

  28. May E, Mouriesse H, May-Levin F,et al: A new approach allowing an early prognosis in breast cancer; The ratio of estrogen receptor (ER) ligand binding activity to the ER-specific mRNA level.Oncogene 4:1037–1042, 1989.

    PubMed  CAS  Google Scholar 

  29. Rennie PS, Mawji NR, Coldman AJ,et al: Relationship between variant forms of estrogen receptor RNA and an apoptosis-related RNA, TRPM-2, with survival in patients with breast cancer.Cancer 72:3648–3654, 1993.

    Article  PubMed  CAS  Google Scholar 

  30. Koike S, Sakai M, Muramatsu M: Molecular cloning and characterization of rat estrogen receptor cDNA.Nucleic Acids Res 15:2499–2513, 1987.

    Article  PubMed  CAS  Google Scholar 

  31. Murphy LD, Dotzlaw H: Variant estrogen receptor mRNA species detected in human breast cancer biopsy samples.Mol Endocrinol 3:687–693, 1989.

    PubMed  CAS  Google Scholar 

  32. Dotzlaw H, Alkhalaf M, Murphy LD: Characterization of estrogen receptor variant mRNAs from human breast cancers.Mol Endocrinol 6:773–785, 1992.

    Article  PubMed  CAS  Google Scholar 

  33. Scott GK, Kushner P, Vigne J-L,et al: Truncated forms of DNA-binding estrogen receptors in human breast cancer.J Clin Invest 88:700–706, 1991.

    Article  PubMed  CAS  Google Scholar 

  34. Wang Y, Missicek RJ: Identification of a dominant negative form of the human estrogen receptor.Mol Endocrinol 5:1707–1715, 1991.

    PubMed  CAS  Google Scholar 

  35. Fuqua SAW, Fitzgerald SD, Allred DC,et al: Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors.Cancer Res 52: 483–486, 1992.

    PubMed  CAS  Google Scholar 

  36. Fuqua SA, Chamness GC, McGuire WL: Estrogen receptor mutations in breast cancer.J Cell Biochem 51:135–139, 1993.

    Article  PubMed  CAS  Google Scholar 

  37. Castle CG, Koltz DM, Fuqua SAW,et al: Coexpression of wild-type and variant oestrogen receptor mRNAs in a panel of human breast cancer cell lines.Br J Cancer 71:974–980, 1995.

    Google Scholar 

  38. Daffada AA, Johnston SRD, Smith IE,et al: Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.Cancer Res 55:288–293, 1995.

    PubMed  CAS  Google Scholar 

  39. Zhang QX, Borg Å, Fuqua SAW: An Exon 5 deletion variant of the estrogen receptor is frequently coexpressed with wildtype receptor in human breast cancer.Cancer Res 53:5882–5884, 1993.

    PubMed  CAS  Google Scholar 

  40. Karnik PS, Kulkarni S, Liu XP,et al: Estrogen receptor mutations in tamoxifen-resistant breast cancer.Cancer Res 54:349–353, 1994.

    PubMed  CAS  Google Scholar 

  41. Hill SM, Fuqua SAW, Chamness GC,et al: Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism.Cancer Res 49:145–148, 1989.

    PubMed  CAS  Google Scholar 

  42. Leygue ER, Watson PH, Murphy LC,et al: Estrogen receptor variants in normal human mammary tissue.JNCI 88:284–290, 1996.

    Article  PubMed  CAS  Google Scholar 

  43. Kobayashi S, Mizuno T, Tobioka N,et al: Sex steroid receptors in diverse human tumors.Gann 73:439–445, 1982.

    PubMed  CAS  Google Scholar 

  44. Villa E, Camellini L, Dugani A,et al: Variant estrogen receptor messenger RNA species detected in human primary hepatocellular carcinoma.Cancer Res 55:498–500, 1995.

    PubMed  CAS  Google Scholar 

  45. Koehorst SG, Jacobs HM, Thijssen JH,et al: Wild type and alternatively spliced estrogen receptor messenger RNA in human meningioma tissue and MCF7 breast cancer cells.J Steroid Biochem Mol Biol 45: 227–233, 1993.

    Article  PubMed  CAS  Google Scholar 

  46. Hirata S, Yamada-Mouri N, Nara M,et al: Presence of alternatively spliced-estrogen receptor mRNA variants in normal human uterine endometrium and endometrial cancer.Endocr J 42:289–293, 1995.

    Article  PubMed  CAS  Google Scholar 

  47. Falette NS, Fuqua SAW, Chamness GC,et al: Estrogen receptor gene methylation in human breast tumors.Cancer Res 50:3974–3978, 1990.

    PubMed  CAS  Google Scholar 

  48. Doucas V, Spyrou G, Yaniv M: Unregulated expression ofc-jun orc-fos protein but notjunD inhibits oestrogen receptor activity in human breast cancer derived cells.EMBO J 10:2237–2245, 1991.

    PubMed  CAS  Google Scholar 

  49. Feavers IM, Jiricny J, Moncharmont B,et al: Interaction of two nonhiston proteins with the avian vitellogenin gene modulates the binding of estradiol-receptor complex.Proc Natl Acad Sci USA 84:7453–7457, 1987.

    Article  PubMed  CAS  Google Scholar 

  50. Edward DP, Kuhnel B, Estes PA: Human progesterone receptor binding to mouse mammary tumor virus deoxyribonucleic acid; Dependence on hormone and non-receptor nuclear factor(s).Mol Endocrinol 3:381–391, 1989.

    Article  Google Scholar 

  51. Burnside J, Darling DS, Chin WW,et al: A nuclear factors that enhances binding of thyroid hormone receptors to thyroid hormone receptor elements.J Biol Chem 265:2500–2504, 1990.

    PubMed  CAS  Google Scholar 

  52. Shiba E, Kambayashi J, Sakon M,et al: Ca2+-dependent neutral proteases (calpain) activity in breast cancer tissue and estrogen receptor status.Breast Cancer 3:13–17, 1996.

    Article  PubMed  Google Scholar 

  53. Srivastava S, Zou Z, Pirollo K,et al: Germline transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.Nature 348:747- 749, 1990.

    Article  PubMed  CAS  Google Scholar 

  54. Emi M: Molecular genetics of familial breast and ovarian cancer.Molecular Medicine 32:262–268, 1995 (in Japanese).

    CAS  Google Scholar 

  55. Newman B, Austin MA, Lee M,et al: Inheritance of human breast cancer; Evidence for autosomal dominant transmission in high-risk families.Proc Natl Acad Sci USA 85:3044–3048, 1988.

    Article  PubMed  CAS  Google Scholar 

  56. Hall JH, Lee MK, Newman B,et al: Linkage of earlyonset familial breast cancer to chromosome 17q21.Science 250:1684–1689, 1990.

    Article  PubMed  CAS  Google Scholar 

  57. Miki Y, Swensen J, Shattuck-Eidens D,et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.Science 266:66–71, 1994.

    Article  PubMed  CAS  Google Scholar 

  58. Wooster R, Neuhausen SL, Mangion J,et al: Localization of a breast cancer susceptibility gene,BRCA2, to chromosome 13ql2-13.Science 265:2088–2090, 1994.

    Article  PubMed  CAS  Google Scholar 

  59. Iwase H, Yamashita H, Kobayashi S,et al: Possibility of the linkage to the estrogen receptor gene in 4 Japanese breast cancer families.Jpn J Breast Cancer 11:117–121, 1996 (in Japanese with English summary).

    Google Scholar 

  60. Smith EP, Boyd J, Frank GR,et al: Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man.N Engl J Med 331:1056–1061, 1994.

    Article  PubMed  CAS  Google Scholar 

  61. Wooster R, Mangion J, Eeles R,et al: A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome.Nature Genet 2:132–134, 1992.

    Article  PubMed  CAS  Google Scholar 

  62. Wanless C, Barker S, Puddefoot JR,et al: Somatic change in the estrogen receptor gene associated with altered expression of the progesterone receptor.Anticancer Res 11:139–142, 1991.

    PubMed  CAS  Google Scholar 

  63. Yaich L, Dupont WD, Cavener DR,et al: Analysis of thePvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood.Cancer Res 52: 77–83, 1992.

    PubMed  CAS  Google Scholar 

  64. Garcia T, Lehrer S, Bloomer WD,et al: A variant estrogen receptor messenger ribonucleic acid is associated with reduced levels of estrogen binding in human mammary tumors.Mol Endocrinol 2:785–791, 1988.

    PubMed  CAS  Google Scholar 

  65. Lehrer S, Sanchez M, Song HK,et al: Oestrogen receptor B - region polymorphism and spontaneous abortion in women with breast cancer.Lancet 335:622- 624, 1990.

    Article  PubMed  CAS  Google Scholar 

  66. Schmultzler RK, Sanchez M, Lehrer S,et al: Incidence of an estrogen receptor polymorphism in breast cancer patients.Breast Cancer Res Treat 19:111–117, 1991.

    Article  Google Scholar 

  67. Berkowitz GS, Stone JL, Lehrer SP,et al: An estrogen receptor genetic polymorphism and the risk of primary and secondary recurrent spontaneous abortion.Am J Obstet Gynecol 171:1579–1584, 1994.

    PubMed  CAS  Google Scholar 

  68. Lehrer S, Levine E, Savoretti P,et al: Oestrogen and progesterone receptor dissociation and familial history of breast cancer.Lancet 339:1108–1109, 1992.

    Article  PubMed  CAS  Google Scholar 

  69. Iwase H, Kobayashi S, Iwata H,et al: Molecular analysis of the estrogen receptor (ER) gene in association with ER negativity in breast cancer.Jpn J Cancer Chemother 23:61–65, 1996 (in Japanese with English summary).

    CAS  Google Scholar 

  70. Sluyser M: Mutations in the estrogen receptor gene.Hum Mutat 6:97–103, 1995.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery II, Nagoya City University Medical School, Kawasumi 1, 467, Mizuho-ku, Nagoya, Japan

    Hirotaka Iwase & Shunzo Kobayashi

Authors
  1. Hirotaka Iwase
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shunzo Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Iwase, H., Kobayashi, S. Alterations and polymorphisms of the estrogen receptor gene in breast cancer. Breast Cancer 4, 57–66 (1997). https://doi.org/10.1007/BF02967058

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02967058

Key words

search

Navigation